Arcutis Eyes Atopic Dermatitis Opportunity With Ducentis Buy

Paying Just $16m Upfront In Cash For UK Biotech

 
• By Kevin Grogan
  
Magnet
The attraction of Arcutis proves strong for Ducentis • Source: Shutterstock

More from Business

More from Scrip